Skip to content

PHARDA: what changed

BE 0474.979.207NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€113,407
2024 · €79,702+€33,705
Equity
€336,326
2024 · €333,919+€2,407
Cash
€148,121
2024 · €196,984-€48,863
Balance sheet total
€575,327
2024 · €647,843-€72,516

Largest movements

2024 to 2025
Assets
  • Cash -€48,863

    down €48,863 (-24.8%), from €196,984 to €148,121

    mainly Contributions, distributions and other (-€111,000) and Other debts (-€37,090)

  • Tangible fixed assets -€37,239

    down €37,239 (-18.0%), from €206,971 to €169,732

  • Stocks and contracts +€35,440

    up €35,440 (+68.6%), from €51,650 to €87,090

  • Current investments -€29,834

    down €29,834 (-22.5%), from €132,500 to €102,666

  • Receivables within one year +€12,273

    up €12,273 (+23.0%), from €53,414 to €65,687

Equity and liabilities
  • Other debts -€37,090

    down €37,090 (-21.8%), from €170,333 to €133,243

  • Trade debts -€13,511

    down €13,511 (-23.2%), from €58,350 to €44,839

  • Debts after one year -€11,548

    down €11,548 (-40.8%), from €28,285 to €16,737

  • Tax, wage and social debts -€11,501

    down €11,501 (-26.7%), from €43,137 to €31,636

    of which Remuneration and social security: -€17,653

Income statement
  • Gross operating margin +€82,931

    up €82,931 (+41.7%), from €198,879 to €281,810

  • Write-downs +€30,533

    first reported in 2025, at €30,533

  • Taxes +€16,628

    up €16,628 (+51.4%), from €32,319 to €48,947

  • Financial charges +€4,031

    up €4,031 (+94.0%), from €4,289 to €8,320

  • Other operating charges -€3,925

    down €3,925 (-98.0%), from €4,007 to €82

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €79,702
Gross operating margin +€82,931
Staff costs -€2,437
Depreciation +€1,102
Write-downs -€30,533
Other operating charges +€3,925
Financial income -€624
Financial charges -€4,031
Taxes -€16,628
Result 2025 €113,407
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€45,106
Investment +€29,834
Financing -€123,803
Cash 2024 €196,984
Net result for the year +€113,407
Depreciation +€37,239
Stocks and contracts -€35,440
Receivables within one year -€12,273
Deferred charges and accrued income +€4,293
Trade debts -€13,511
Tax, wage and social debts -€11,501
Other debts -€37,090
Accrued charges and deferred income -€18
Current investments +€29,834
Debts after one year -€11,548
Current portion of long-term debt -€1,255
Contributions, distributions and other -€111,000
Cash 2025 €148,121
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €647,843 €575,327 -€72,516 -11.2%
Fixed assets 21/28 €206,971 €169,732 -€37,239 -18.0%
Tangible fixed assets 22/27 €206,971 €169,732 -€37,239 -18.0%
Land and buildings 22 €91,924 €83,116 -€8,808 -9.6%
Plant, machinery and equipment 23 €75,875 €58,430 -€17,445 -23.0%
Furniture and vehicles 24 €39,171 €28,185 -€10,986 -28.0%
Current assets 29/58 €440,872 €405,595 -€35,277 -8.0%
Stocks and contracts in progress 3 €51,650 €87,090 +€35,440 +68.6%
Stocks 30/36 €51,650 €87,090 +€35,440 +68.6%
Amounts receivable within one year 40/41 €53,414 €65,687 +€12,273 +23.0%
Trade receivables 40 €53,414 €65,687 +€12,273 +23.0%
Current investments 50/53 €132,500 €102,666 -€29,834 -22.5%
Cash at bank and in hand 54/58 €196,984 €148,121 -€48,863 -24.8%
Deferred charges and accrued income 490/1 €6,324 €2,031 -€4,293 -67.9%
Total equity and liabilities 10/49 €647,843 €575,327 -€72,516 -11.2%
Equity 10/15 €333,919 €336,326 +€2,407 +0.7%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €327,719 €329,719 +€2,000 +0.6%
Distributable reserves 133 €327,719 €329,719 +€2,000 +0.6%
Profit (loss) carried forward 14 €0 €407 +€407
Amounts payable 17/49 €313,924 €239,001 -€74,923 -23.9%
Amounts payable after more than one year 17 €28,285 €16,737 -€11,548 -40.8%
Financial debts 170/4 €28,285 €16,737 -€11,548 -40.8%
Amounts payable within one year 42/48 €285,575 €222,218 -€63,358 -22.2%
Current portion of amounts payable after more than one year 42 €13,755 €12,500 -€1,255 -9.1%
Trade debts 44 €58,350 €44,839 -€13,511 -23.2%
Suppliers 440/4 €58,350 €44,839 -€13,511 -23.2%
Taxes, remuneration and social security 45 €43,137 €31,636 -€11,501 -26.7%
Taxes 450/3 €20,509 €26,661 +€6,152 +30.0%
Remuneration and social security 454/9 €22,628 €4,975 -€17,653 -78.0%
Other amounts payable 47/48 €170,333 €133,243 -€37,090 -21.8%
Accrued charges and deferred income 492/3 €64 €46 -€18 -27.9%
Remuneration, social security and pensions 62 €43,684 €46,122 +€2,437 +5.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €38,341 €37,239 -€1,102 -2.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €30,533 +€30,533
Other operating charges 640/8 €4,007 €82 -€3,925 -98.0%
Gross operating margin 9900 €198,879 €281,810 +€82,931 +41.7%
Operating profit (loss) 9901 €112,846 €167,834 +€54,988 +48.7%
Financial income 75/76B €3,464 €2,840 -€624 -18.0%
Recurring financial income 75 €3,464 €2,840 -€624 -18.0%
Financial charges 65/66B €4,289 €8,320 +€4,031 +94.0%
Recurring financial charges 65 €4,289 €8,320 +€4,031 +94.0%
Profit (loss) for the period before taxes 9903 €112,021 €162,354 +€50,333 +44.9%
Income taxes 67/77 €32,319 €48,947 +€16,628 +51.4%
Profit (loss) for the period 9904 €79,702 €113,407 +€33,705 +42.3%
Profit (loss) for the period to be appropriated 9905 €79,702 €113,407 +€33,705 +42.3%

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€466,481 to €585,808

Midpoint €516,201 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €336,326
Capitalised earnings €596,636 to €835,290
Indication €466,481 to €585,808

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€336,326
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€336,326

Capitalised earnings

net result for the year (9904)
2025
€113,407
2024
€79,702
2023
€57,479
2022
€96,043
excluding non-recurring income and charges
€96,556
2021
€16,226
Average result
€83,529
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€596,636 / €696,075 / €835,290

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.